Clinical Trial Update: A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome [Phase 3]

View source ↗

Summary

The document reports on a Phase 3 clinical trial evaluating NNZ-2591 in pediatric participants with Phelan-McDermid Syndrome, with recruitment currently ongoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phelan-mcdermid Syndrome

Drugs mentioned

• NNZ-2591 (NNZ-2591)

Snippet

Sponsor: Neuren Pharmaceuticals Limited | Conditions: Phelan-McDermid Syndrome | Phase 3 | Status: RECRUITING